Robert W. Cross

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · Science Translational Medicine · 2021 · 497 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang et al. · Cell Reports · 2022 · 464 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Lassa Fever in Post-Conflict Sierra Leone

Jeffrey G. Shaffer, Donald S. Grant, John S. Schieffelin et al. · PLoS neglected tropical diseases · 2014 · 236 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Establishment of an African green monkey model for COVID-19 and protection against re-infection

Courtney Woolsey, Viktoriya Borisevich, Abhishek N. Prasad et al. · Nature Immunology · 2020 · 222 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy

Chad E. Mire, Benjamin A. Satterfield, Joan B. Geisbert et al. · Scientific Reports · 2016 · 212 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17